Literature DB >> 3096793

Molecular composition of luteinizing hormone and follicle-stimulating hormone in commercial gonadotropin preparations.

J Harlin, S A Khan, E Diczfalusy.   

Abstract

The biologic (B) and immunologic (I) properties of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) were studied in three commercial urinary gonadotropin preparations and in the first international standard preparation of human urinary gonadotropins before and after fractionation by isoelectrofocusing (IEF). Significant differences were found in the IEF profiles of both bioactive and immunoreactive LH and FSH and in the B/I ratios of the preparations studied. The observed differences in the molecular composition of LH and FSH seem to be attributable to the purification procedures employed. The possible influence of these differences on the in vivo potencies, circulating half-lives, and clinical effects of gonadotropin preparations are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096793     DOI: 10.1016/s0015-0282(16)49879-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

Review 1.  In vitro bioassays of follicle-stimulating hormone: methods and clinical applications.

Authors:  M Simoni; E Nieschlag
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

Review 2.  Glycoprotein hormone isomorphism and assay discrepancy: the paradigm of luteinizing hormone (LH).

Authors:  S Costagliola; P Niccoli; P Carayon
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

3.  Molecular composition of two different batches of urofollitropin: analysis by immunofluorimetric assay, radioligand receptor assay and in vitro bioassay.

Authors:  M Simoni; G F Weinbauer; E Nieschlag
Journal:  J Endocrinol Invest       Date:  1993-01       Impact factor: 4.256

4.  Establishment of an in vitro bioassay and radio receptor assay for LH/CG in human sera using immortalized granulosa cells transfected with LH/CG receptor.

Authors:  N Selvaraj; A Dantes; R Limor; A Golander; A Amsterdam
Journal:  Endocrine       Date:  1996-12       Impact factor: 3.633

5.  Biological activity and metabolic clearance of recombinant human follicle stimulating hormone produced in Sp2/0 myeloma cells.

Authors:  C K Chin; P R Schofield; D M Robertson; P P Gray; W Chotigeat; S M Mahler
Journal:  Cytotechnology       Date:  1996-06       Impact factor: 2.058

Review 6.  Hormonal Stimulation of Human Ovarian Xenografts in Mice: Studying Folliculogenesis, Activation, and Oocyte Maturation.

Authors:  Monica Anne Wall; Vasantha Padmanabhan; Ariella Shikanov
Journal:  Endocrinology       Date:  2020-12-01       Impact factor: 4.736

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.